Elanco Animal Health Strengthens Board with New Appointment
Company Announcements

Elanco Animal Health Strengthens Board with New Appointment

Elanco Animal Health ( (ELAN) ) has provided an update.

Elanco Animal Health has appointed Dr. Stacey Ma to its Board of Directors, enhancing its expertise in biopharmaceutical development and manufacturing. Dr. Ma, currently with Gilead Sciences, brings a wealth of experience in product and portfolio strategy, technical development, and manufacturing operations. Her leadership and innovative approach are expected to significantly contribute to Elanco’s mission of advancing animal health and bolstering its Innovation, Science and Technology Committee.

See more insights into ELAN stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyElanco price target raised to $20 from $19 at Barclays
TipRanks Auto-Generated NewsdeskElanco Animal Health Reports Steady Growth in Q3 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App